BATS · GSKH
Precidian ETFs Trust GSK plc
Financial Services · Asset Management
$70.43
Down-$1.35 (-1.89%)
Updated Sep 19, 2026, 11:40 AM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 694.47K
- P/E ratio
- —
- Dividend yield
- 1.12%
- 52-week range
- $66.84 – $82.02
- Volume
- 1.01K
- Avg. volume
- 342
Price performance
GSKH price history
1M range · 0 trading sessions · Daily adjusted prices
GSKH does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest GSKH news
The latest Smart Investors Daily articles mentioning GSKH.
Stock researchCompany · Overview
GSKH research
Overview
Company profile and research snapshot.
Company profile
The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of GSK plc (the “Company”). The series will not invest directly in the company. The fund is non-diversified.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
